Key result
In children with functionally single-ventricle disease undergoing staged palliation, 52.3% required at least one additional procedure during a median follow-up of 5.4 years.
Why the study?
Additional procedures are an important metric for healthcare evaluation, prompting the evaluation of surgical and catheter reintervention rates in children with functionally single-ventricle congenital heart disease undergoing staged palliation.
Cohort (n=3,307)
Yes
Additional procedures are highly common in children undergoing staged palliation for functionally single-ventricle disease, affecting over half of patients, highlighting the need for interventions to reduce these adverse outcomes.
Background: Given their importance as a metric for health care evaluation, this study's aim was to evaluate the rates of surgical and catheter reinterventions for children with functionally single-ventricle (f-SV) congenital heart disease (CHD) undergoing staged palliation. Methods: We undertook a retrospective cohort study of children born with f-SV CHD between 2000 and 2018 in England and Wales, using the national registry, with survival ascertained in 2020. Competing risk analysis was used to describe the incidence of additional procedures that occurred first, during follow-up, accounting for competing events of death or transplantation. Results: Of 56,039 patients who received an intervention for CHD, 3307 (5.9%) had f-SV. The largest diagnostic subcategories were hypoplastic left heart syndrome (1266 [38.3%]), tricuspid atresia (448 [13.5%]), and double-inlet left ventricle (328 [9.9%]). During a median follow-up of 5.4 (interquartile range, 0.8-10.8) years, 921 (27.9%) patients had at least 1 additional interstage surgery and 1293 (39.1%) had at least 1 additional interstage catheter intervention. The cumulative incidence of additional surgery at 6 months after stage 1 was 17.6% (95% CI, 16.2%-19.0%); at 2 years after stage 2, 8.3% (7.2%-9.5%); and at 5 years after stage 3, 8.4% (7.0%-9.9%). The cumulative incidence of additional catheter at 6 months after stage 1 was 18.0% (16.6%-19.4%); at 2 years after stage 2, 14.7% (13.3%-16.2%); and at 5 years after stage 3, 23.7% (21.5%-26.0%). Conclusions: It is important to quantify additional procedures for children with f-SV disease to inform parents and health professionals, potentially facilitating the development of interventions that aim to reduce these important adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2023) conducted a cohort in Functionally single-ventricle congenital heart disease (n=3,307). Staged palliation for functionally single-ventricle disease was evaluated on Any additional cardiac operation or interventional catheter procedure over and above the treatment pathway. In children with functionally single-ventricle disease undergoing staged palliation, 52.3% required at least one additional procedure during a median follow-up of 5.4 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: